Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before.
Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before. The company had net income for the year of $2.4 million, compared with a net loss of $352,000 in 1997. The 1998 figures include a one-time patent litigation settlement of $600,000.
Schick reported that sales of its accuDEXA bone densitometer are going well. In addition, the Long Island City, NY, company reported that it received 510(k) clearance from the Food and Drug Administration for an additional application for accuDEXA: use of the system to help physicians determine the risk of fracture. AccuDEXA received its initial 510(k) market clearance in December for assessing bone mineral density (SCAN 4/15/98).
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.